Crescita Therapeutics (TSE:CTX) Announces Earnings Results

Crescita Therapeutics (TSE:CTX) released its quarterly earnings data on Tuesday. The company reported C($0.04) earnings per share (EPS) for the quarter, FiscalAI reports. The company had revenue of C$5.96 million for the quarter. Crescita Therapeutics had a return on equity of 2.92% and a net margin of 2.07%.

Crescita Therapeutics Stock Down 1.3%

CTX opened at C$0.74 on Wednesday. The firm’s 50-day simple moving average is C$0.55 and its 200-day simple moving average is C$0.49. The company has a debt-to-equity ratio of 2.98, a quick ratio of 2.29 and a current ratio of 3.12. Crescita Therapeutics has a twelve month low of C$0.40 and a twelve month high of C$0.75. The firm has a market cap of C$13.77 million, a price-to-earnings ratio of 37.00 and a beta of -0.39.

About Crescita Therapeutics

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.